Scientists have hijacked the herpes virus and turned it into a cancer-busting ally. A decade after the United States Food and Drug Administration (FDA) approved the first virus-based cancer therapy, ...

・Clinical-stage pharma stock Theralase Technologies (TSXV:TLT) announced a significant breakthrough in the treatment of Herpes Simplex Viruses (HSV) ・Independent research conducted at the University ...

Get up to speed on herpes simplex virus (HSV-1/HSV-2) epidemiology, novel antibodies, vaccine development, and cure ...

Assembly Biosciences, Inc. (NASDAQ:ASMB) released interim pharmacokinetic (PK) and safety results from healthy participants in the Phase 1a portion of its ongoing Phase 1a/b study of ABI-5366, an ...

The market growth can be attributed to the growing concerns over HSV infection, including, oral and genital herpes. Moreover, the infection is highly contagious, spreading via saliva, vaginal ...

— Dr. David Ginn, Senior VP of Research and Development at Erroll McCoy AUGUSTA, GA, UNITED STATES, December 12, 2024 /EINPresswire.com/ -- Erroll McCoy is excited ...

Approximately two-thirds of the world's population under the age of 50 years have oral or genital herpes simplex type 1 (HSV-1) infection, while one in eight have herpes simplex type 2 (HSV-2) ...

Researchers have found in a new study published in JAMA that valacyclovir showed no efficacy and was associated with ...

People given the herpes medication valacyclovir actually experienced worse cognitive decline than those given a placebo.

Mounting evidence points to a connection between dementia and common herpes virus infections, particularly herpes simplex virus type 1 (HSV-1), which causes cold sores, and varicella zoster virus (VZV ...

Theralase® validates previous University of Manitoba research by demonstrating that RuvidarTM is safe and effective in the treatment of the Herpes Simplex Virus in an animal model. TORONTO, ON / ...